Overview
Junctional epidermolysis bullosa (JEB) is a rare and serious inherited skin condition where the skin and mucous membranes are extremely fragile. In healthy skin, different layers are held together by proteins that act like anchors. In JEB, mutations in the genes that make these anchoring proteins cause the layers to separate easily, leading to painful blisters and open wounds that form with very little friction or trauma — sometimes even from normal handling or clothing. JEB is one of the main types of epidermolysis bullosa (EB), a group of conditions sometimes called 'butterfly skin' because the skin is as fragile as a butterfly's wings. JEB affects not just the outer skin but also the moist linings inside the body, including the mouth, throat, esophagus, airways, eyes, and urinary tract. This means eating, swallowing, and breathing can all be affected. Blistering at birth or shortly after is common, and wounds can be slow to heal and prone to infection. Some forms of JEB are very severe and life-threatening in infancy, while others are milder and allow survival into adulthood. There is currently no cure for JEB, but treatment focuses on careful wound care, preventing infection, managing pain, and supporting nutrition. A gene therapy product called beremagene geperpavec (B-VEC, brand name Vyjuvek) has received FDA approval for a related form of EB, and research into gene and cell therapies for JEB is actively ongoing. A team of specialists is usually needed to manage this complex condition.
Also known as:
Key symptoms:
Blisters forming on the skin with little or no injuryOpen sores and wounds that are slow to healBlistering inside the mouth and throatDifficulty swallowing due to blisters in the esophagusHoarse voice or breathing problems from blisters in the airwayEye irritation, redness, or scarringNail loss or abnormal nail growthHair loss (in some subtypes)Dental problems including tooth decay and enamel defectsScarring of the skin over timeAnemia (low red blood cell count) from chronic woundsPoor growth and low body weight due to feeding difficultiesUrinary problems from blistering in the urinary tractIncreased risk of skin infection
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
2 eventsTreatment of wounds associated with dystrophic and junctional epidermolysis bullosa (EB) in adult and pediatric patients 6 months of age and older
University of Southern California — PHASE1, PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
1 availableFilsuvez
Treatment of wounds associated with dystrophic and junctional epidermolysis bullosa (EB) in adult and pediatric patients 6 months of age and older
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesTravel Grants
No travel grants are currently matched to Junctional epidermolysis bullosa.
Community
No community posts yet. Be the first to share your experience with Junctional epidermolysis bullosa.
Start the conversation →Latest news about Junctional epidermolysis bullosa
No recent news articles for Junctional epidermolysis bullosa.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Which specific subtype of JEB does my child or I have, and what does that mean for the long-term outlook?,Which genes are affected, and should other family members be tested?,What wound care routine and dressings do you recommend, and can we get training from a wound care nurse?,Are there any clinical trials for gene therapy or other new treatments that we might qualify for?,How should we handle a skin infection or breathing emergency at home?,What specialists should be part of our care team, and how often should we see each one?,What support resources or patient organizations do you recommend for families living with JEB?
Common questions about Junctional epidermolysis bullosa
What is Junctional epidermolysis bullosa?
Junctional epidermolysis bullosa (JEB) is a rare and serious inherited skin condition where the skin and mucous membranes are extremely fragile. In healthy skin, different layers are held together by proteins that act like anchors. In JEB, mutations in the genes that make these anchoring proteins cause the layers to separate easily, leading to painful blisters and open wounds that form with very little friction or trauma — sometimes even from normal handling or clothing. JEB is one of the main types of epidermolysis bullosa (EB), a group of conditions sometimes called 'butterfly skin' because
How is Junctional epidermolysis bullosa inherited?
Junctional epidermolysis bullosa follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Junctional epidermolysis bullosa typically begin?
Typical onset of Junctional epidermolysis bullosa is neonatal. Age of onset can vary across affected individuals.
Are there clinical trials for Junctional epidermolysis bullosa?
Yes — 1 recruiting clinical trial is currently listed for Junctional epidermolysis bullosa on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Junctional epidermolysis bullosa?
25 specialists and care centers treating Junctional epidermolysis bullosa are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.